Intracellular Pathogens and Innate Immunity
细胞内病原体和先天免疫
基本信息
- 批准号:7177234
- 负责人:
- 金额:$ 5.76万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2004
- 资助国家:美国
- 起止时间:2004-09-30 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Macrophages play pivotal roles in the biology of infectious diseases as hosts to intracellular pathogens, mediators of inflammation, and orchestrators of acquired immunity. It is no surprise that among most of the NIAID priority pathogens, macrophages are critical to the outcome of infection. A central hypothesis of this Program Project is that intracellular pathogens manipulate the response of macrophages to promote disease. Furthermore, the transcriptional response of macrophages to infection serves as a fundamental read-out of the overall response.
The purpose of this Program Project is to use a taxonomically and structurally distinct and clinically relevant panel of intracellular pathogens to establish the transcription profile of macrophages in response to microbial infection using a newly developed and novel microarray containing probes for all known mouse genes (Core B). This transcriptional profile will then serve as a benchmark to understand how the host response is manipulated by each pathogen. By profiling the transcriptional response of macrophages to microbial mutants that are defective in their pathogenic interactions with macrophages, we will learn how pathogens manipulate host cells to promote infection. By using macrophages derived from knockout mice in combination with microbial mutants, we will identify the pathways of innate immune recognition that determine the host response and how pathogens can manipulate these pathways for their benefit. These studies will illuminate essential and conserved pathways of macrophage control of innate immunity, thereby providing potential targets of therapeutic intervention as well as pathogenic signatures that will serve to uncover basic mechanisms of microbial pathogenesis and host response. The specific Aims are to (1) Identify microbial determinants of pathogenesis that affect macrophage innate immune responses in Listeria monocytogenes, Francisella tularensis, Mycobacterium tuberculosis and Histoplasma capsulatum; (2) Characterize the intracellular replication and trafficking of microbial mutants in bone marrow-derived macrophages. (3) Characterize host gene expression profiles using custom synthesized DNA microarrays in response to wild-type and mutant microbial pathogens in macrophages from wild-type and mutant mice.
巨噬细胞作为细胞内病原体的宿主、炎症的介质和获得性免疫的协调者,在传染病的生物学中发挥着关键作用。在大多数NIAID优先病原体中,巨噬细胞对感染的结果至关重要,这并不奇怪。本项目的一个中心假设是细胞内病原体操纵巨噬细胞的反应来促进疾病。此外,巨噬细胞对感染的转录反应是整体反应的基本解读。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL A PORTNOY其他文献
DANIEL A PORTNOY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL A PORTNOY', 18)}}的其他基金
The role of Listeria cyclic-di-AMP during infection and immunity
李斯特菌环二腺苷在感染和免疫过程中的作用
- 批准号:
8234225 - 财政年份:2011
- 资助金额:
$ 5.76万 - 项目类别:
Listeria-based vaccines engineered to modulate the innate immune system
基于李斯特菌的疫苗旨在调节先天免疫系统
- 批准号:
8296801 - 财政年份:2011
- 资助金额:
$ 5.76万 - 项目类别:
Project 1: Listeria metabolites and innate immunity
项目1:李斯特菌代谢物与先天免疫
- 批准号:
10190578 - 财政年份:2004
- 资助金额:
$ 5.76万 - 项目类别:
The intersection of innate and adaptive immunity to intracellular pathogens
针对细胞内病原体的先天免疫和适应性免疫的交叉点
- 批准号:
10655288 - 财政年份:2004
- 资助金额:
$ 5.76万 - 项目类别:
Project 1: Innate immune responses triggered by Listeria monocytogenes
项目1:单增李斯特菌引发的先天免疫反应
- 批准号:
9977105 - 财政年份:2004
- 资助金额:
$ 5.76万 - 项目类别:
The intersection of innate and adaptive immunity to intracellular pathogens
针对细胞内病原体的先天免疫和适应性免疫的交叉点
- 批准号:
10400179 - 财政年份:2004
- 资助金额:
$ 5.76万 - 项目类别:
相似国自然基金
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
- 批准号:82371028
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
- 批准号:82371651
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
NPM1表观重塑巨噬细胞代谢及修复表型在心肌缺血损伤中的调控作用
- 批准号:82371825
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
IL-4协同精氨酸优化种植初期巨噬细胞胞葬作用和成骨微环境的作用及机制研究
- 批准号:82370923
- 批准年份:2023
- 资助金额:48.00 万元
- 项目类别:面上项目
HK2乳酰化修饰介导巨噬细胞功能障碍在脓毒症中的作用及机制
- 批准号:82372160
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
转运蛋白RCP调控巨噬细胞脂肪酸氧化参与系统性红斑狼疮发病的机制研究
- 批准号:82371798
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
蛋白精氨酸甲基化转移酶PRMT5调控PPARG促进巨噬细胞M2极化及其在肿瘤中作用的机制研究
- 批准号:82371738
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
- 批准号:82300356
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
Macrophage和Treg在移植免疫调节中的相互作用及其机制研究
- 批准号:81102247
- 批准年份:2011
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
肢体缺血后适应抑制肺泡巨噬细胞活化及防治肺缺血再灌注损伤机制的研究
- 批准号:81070041
- 批准年份:2010
- 资助金额:32.0 万元
- 项目类别:面上项目
相似海外基金
Anti-Complement Immunotherapy for Pancreatic Cancer
胰腺癌的抗补体免疫治疗
- 批准号:
10751872 - 财政年份:2024
- 资助金额:
$ 5.76万 - 项目类别:
Investigating the role of intestinal microbiota in intestinal macrophage immune memory
研究肠道微生物群在肠道巨噬细胞免疫记忆中的作用
- 批准号:
491179 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别:
Fellowship Programs
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
KRAS 抑制剂可引发巨噬细胞介导的破坏癌细胞
- 批准号:
10638364 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别:
Role of STING in Cholestatic Liver Injury
STING 在胆汁淤积性肝损伤中的作用
- 批准号:
10637131 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别:
THE IMMUNE SELF-ASSOCIATED STORAGE ORGANELLE (SASO)
免疫自联存储细胞器 (SASO)
- 批准号:
10639168 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别:
Using trained immunity-inhibiting nanobiologics to achieve tolerance of heart allografts in non-human primates
使用经过训练的免疫抑制纳米生物制剂来实现非人类灵长类动物同种异体心脏移植的耐受性
- 批准号:
10642598 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别:
NLRP10 Inflamasome in Gram-positive Sepsis
革兰氏阳性脓毒症中的 NLRP10 炎性体
- 批准号:
10680214 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别:
FOXA1 regulates cytokine signaling and immune landscape in prostate cancer through ARID1A
FOXA1 通过 ARID1A 调节前列腺癌中的细胞因子信号传导和免疫景观
- 批准号:
10681898 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别:
Role of Lysosome Damage in ALD Pathogenesis
溶酶体损伤在 ALD 发病机制中的作用
- 批准号:
10668006 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别:
Regulation of RNA sensing and viral restriction by RNA structures
RNA 结构对 RNA 传感和病毒限制的调节
- 批准号:
10667802 - 财政年份:2023
- 资助金额:
$ 5.76万 - 项目类别: